Glossary
HTA Glossary: Health Technology Assessment Terms
Short, plain-language definitions of the terms used in health technology assessment, health economics and market access. Each entry gives a definition you can quote, a brief explanation, the formula where there is one, and links to a full article and the matching course module.
Budget impact
Budget impact is the expected change in a health care payer's spending after a new technology is adopted. A budget impact analysis (BIA) estimates it by comparing total costs in a scenario with the new technology against a scenario without it, year by year, for all patients eligible for treatment.
Read moreCost-effectiveness plane
The cost-effectiveness plane is a graph that plots the difference in health effects between a new technology and its comparator on the horizontal axis and the difference in costs on the vertical axis. Its four quadrants show whether the new technology is more or less effective and more or less costly.
Read moreDisability-adjusted life year (DALY)
A disability-adjusted life year (DALY) is a measure of disease burden that represents one year of healthy life lost. It adds the years of life lost to premature death (YLL) to the years lived with disability (YLD), so it captures both early death and ill health in a single number.
Read moreDiscounting
Discounting is the adjustment that converts costs and health effects occurring in future years into their present value, so that options with different timing can be compared fairly. Each future amount is divided by one plus the annual discount rate, raised to the power of the number of years ahead.
Read moreHazard ratio (HR)
A hazard ratio (HR) compares the rate at which an event, such as death or disease progression, occurs in one group with the rate in another group during the follow-up of a study. A hazard ratio of 1 means no difference; a value below 1 means the event occurs at a lower rate in the treatment group.
Read moreHealth economics and outcomes research (HEOR)
Health economics and outcomes research (HEOR) is the field that studies the value of health care interventions by measuring their costs and their clinical, economic and patient-reported outcomes. It produces evidence such as economic models, real-world studies and quality-of-life data that payers and HTA bodies use when they make decisions.
Read moreHealth technology assessment (HTA)
Health technology assessment (HTA) is a structured, multidisciplinary way of judging the value of a health technology. It compares a medicine, device, diagnostic test, procedure or programme with the existing alternatives on clinical benefit, safety, cost and wider consequences, so that decisions on funding and use rest on evidence.
Read moreIncremental cost-effectiveness ratio (ICER)
The incremental cost-effectiveness ratio (ICER) is the extra cost of one health technology compared with another, divided by the extra health benefit it produces. It is usually expressed as a cost per quality-adjusted life year (QALY) gained and is set against a willingness-to-pay threshold to judge value for money.
Read moreMarkov model
A Markov model is a type of economic model that represents a disease as a set of mutually exclusive health states and moves a group of patients between them in fixed time steps called cycles. The costs and health outcomes attached to each state are added up over the time horizon of the model.
Read moreNet monetary benefit (NMB)
Net monetary benefit (NMB) expresses the result of an economic evaluation in money: the health gain from a technology is multiplied by the willingness-to-pay threshold, and the cost is subtracted. A positive incremental net monetary benefit means that the technology is cost-effective at that threshold.
Read moreNumber needed to treat (NNT)
The number needed to treat (NNT) is the average number of patients who must receive a treatment, instead of the comparator, for one additional patient to benefit over a stated period. It is the reciprocal of the absolute risk reduction, so a smaller NNT means a more effective treatment.
Read morePICO
PICO is a framework that defines a research or assessment question through four elements: Population, Intervention, Comparator and Outcomes. In HTA it sets the scope of an assessment by stating which patients, which technology, which alternatives and which results the evidence must cover, before any data are reviewed.
Read moreQuality-adjusted life year (QALY)
A quality-adjusted life year (QALY) is a measure of health benefit that combines length of life and health-related quality of life in a single number. One QALY equals one year lived in full health. QALYs are calculated by multiplying the time spent in each health state by the utility value of that state.
Read moreUtility value
A utility value, also called a health state utility, is a number that expresses how good or bad a health state is on a scale where 1 represents full health and 0 represents being dead. Utility values are the quality-of-life weights used to calculate quality-adjusted life years (QALYs).
Read moreWillingness-to-pay threshold (WTP)
A willingness-to-pay threshold, also called a cost-effectiveness threshold, is the maximum amount a decision-maker is prepared to pay for one extra unit of health benefit, usually one quality-adjusted life year (QALY). A technology whose ICER falls below the threshold is generally regarded as cost-effective.
Read more
Definitions are written by the HTA Course team in our own words and checked against primary sources such as the NICE glossary, the HTA Glossary (htaglossary.net), ISPOR and the Cochrane Handbook. For longer explanations see the HTA blog, and to check a number try the free calculators.